✦ LIBER ✦

Who defines resistance? the clinical and economic impact of antimicrobial susceptibility testing breakpoints

✍ Scribed by James H Jorgensen

Book ID: 117823420
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 65 KB
Volume: 15
Category: Article
ISSN: 1045-1870
DOI: 10.1053/j.spid.2004.01.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical impact of same-day antimicr

The clinical impact of same-day antimicrobial susceptibility testing

✍ Gary V. Doern 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 648 KB

Assessment of the Phoenix™ automated sys

Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms

✍ T. Giani; M. I. Morosini; M. M. D’Andrea; M. García-Castillo; G. M. Rossolini; R 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Clinical breakpoint changes and their im

Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia

✍ A. K. van der Bij; K. van Dijk; J. Muilwijk; S. F. T. Thijsen; D. W. Notermans; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Clinical breakpoints for antimicrobial a

Clinical breakpoints for antimicrobial agents in pulmonary infections and sepsis: Report of The Committee for Japanese Standards for Antimicrobial Susceptibility Testing for Bacteria

✍ Atsushi Saito 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 371 KB

The Impact of Antimicrobial Resistance o

The Impact of Antimicrobial Resistance on Health and Economic Outcomes

✍ Eliopoulos, G. M.; Cosgrove, S. E.; Carmeli, Y. 📂 Article 📅 2003 🏛 University of Chicago Press 🌐 English ⚖ 76 KB

Drug Resistance in Leishmania Parasites

Drug Resistance in Leishmania Parasites || The Relevance of Susceptibility Tests, Breakpoints, and Markers

✍ Ponte-Sucre, Alicia; Diaz, Emilia; Padrón-Nieves, Maritza 📂 Article 📅 2012 🏛 Springer Vienna 🌐 German ⚖ 471 KB

One of the main problems concerning therapeutic tools for the treatment of parasitic diseases, including leishmaniasis, is that some field parasites are naturally resistant to the classical drugs; additionally, current therapies may select parasites prone to be resistant to the applied drugs. These